Lipoprotein (a) concentrations and apolipoprotein (a) phenotypes in normoglycaemic relatives of type 2 diabetic patients

Atherosclerosis. 1996 Jul;124(1):119-24. doi: 10.1016/0021-9150(96)05830-3.

Abstract

Serum lipoprotein (a) concentrations (Lp(a)) are largely under genetic control, and are strong predictors of coronary heart disease. It has been hypothesised that Lp(a) may contribute to the increased risk of coronary heart disease in familial Type 2 diabetes mellitus. We therefore examined the Lp(a) concentrations and the apolipoprotein (a) (apo(a)) phenotypes in 126 normoglycaemic first degree relatives from families with two or more living Type 2 diabetic patients. These were compared with 147 sex matched normoglycaemic control subjects with no family history of diabetes. Lp(a) concentrations were measured using an enzyme-linked immunosorbent assay (ELISA), and apo(a) isoforms were determined and classified according to the relative mobility of apo(a) on sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), relative to that of apolipoprotein B-100. There were no significant differences in Lp(a) concentrations between the relatives (R) and controls (C): 11.2 (R) vs. 11.1 (C) mg/dl (median). The distribution of apo(a) phenotypes was not significantly different between groups 0.65 (R) vs. 0.67 (C). These results show that first degree relatives at risk of developing Type 2 diabetes do not have abnormal Lp(a) concentrations or apo(a) phenotypes.

MeSH terms

  • Adult
  • Apolipoproteins / genetics*
  • Apoprotein(a)
  • Blood Glucose / analysis*
  • Coronary Disease / epidemiology
  • Coronary Disease / genetics
  • Diabetes Mellitus, Type 2 / genetics*
  • Disease Susceptibility
  • Family Health
  • Female
  • Glucose Tolerance Test
  • Humans
  • Lipoprotein(a) / analysis*
  • Male
  • Middle Aged
  • Phenotype
  • Risk Factors

Substances

  • Apolipoproteins
  • Blood Glucose
  • Lipoprotein(a)
  • Apoprotein(a)